{"DataElement":{"publicId":"3261562","version":"1","preferredName":"HER2 ERBB2 Minimum Nuclei Positive Percent Number","preferredDefinition":"Numeric value that represents the minimum percent HER2/ERBB2 positive nuclei using the IHC method to determine a positive finding.","longName":"3086976v1.0:3261485v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3086976","version":"1","preferredName":"HER2 ERBB Positive Finding","preferredDefinition":"An observation confirming something, such as the presence of a disease, condition, or microorganism._Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc_The ERBB2 Gene at 17q21.1 encodes ERRB2 Receptor Protein Tyrosine Kinase, a 185 kD type I membrane glycoprotein that controls cell growth with features similar to EGFR. Ligand binding increases phosphorylation of tyrosine residues. A potential heterodimer with ERBB3 and ERBB4 receptors, p185ERBB2 is an essential component of the heregulin/neuregulin receptor complex. ERBB2 homodimers do not bind heregulin but ERBB2/ERBB3 heterodimers do. Neuregulins do not interact with ERBB2 alone. The IL6 cytokine induces tyrosine phosphorylation of ERBB2 and ERBB3, but not EGFR. ERBB2 forms an IL6-dependent complex with the IL6R gp130 subunit resulting in MAPK activation. Expressed in fetal kidney and liver, herstatin is a 68 kD secreted product of an alternative ERBB2 transcript that retains intron 8. Herstatin binds p185ERBB2 as an inhibitor by disrupting ERBB2 dimers and reducing p185 tyrosine phosphorylation.  (from SWISS-PROT, OMIM and NCI)_An observation confirming something, such as the presence of a disease, condition, or microorganism.","longName":"2224542v1.0:2639100v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2224542","version":"1","preferredName":"HER2/neu Biomarker","preferredDefinition":"The ERBB2 Gene at 17q21.1 encodes ERRB2 Receptor Protein Tyrosine Kinase, a 185 kD type I membrane glycoprotein that controls cell growth with features similar to EGFR. Ligand binding increases phosphorylation of tyrosine residues. A potential heterodimer with ERBB3 and ERBB4 receptors, p185ERBB2 is an essential component of the heregulin/neuregulin receptor complex. ERBB2 homodimers do not bind heregulin but ERBB2/ERBB3 heterodimers do. Neuregulins do not interact with ERBB2 alone. The IL6 cytokine induces tyrosine phosphorylation of ERBB2 and ERBB3, but not EGFR. ERBB2 forms an IL6-dependent complex with the IL6R gp130 subunit resulting in MAPK activation. Expressed in fetal kidney and liver, herstatin is a 68 kD secreted product of an alternative ERBB2 transcript that retains intron 8. Herstatin binds p185ERBB2 as an inhibitor by disrupting ERBB2 dimers and reducing p185 tyrosine phosphorylation.  (from SWISS-PROT, OMIM and NCI):Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc","longName":"C17756:C16342","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ERBB2 Gene","conceptCode":"C17756","definition":"This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F600421C-63A2-0246-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-04","endDate":null,"createdBy":"HACKETTK","dateCreated":"2005-05-04","modifiedBy":"ONEDATA","dateModified":"2005-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2639100","version":"1","preferredName":"Positive Finding","preferredDefinition":"An observation confirming something, such as the\r\npresence of a disease, condition, or microorganism.","longName":"C38758","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30AFB539-A9E3-5AEB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-17","modifiedBy":"ONEDATA","dateModified":"2007-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D06853-4B12-8BAB-E040-BB89AD432CB0","latestVersionIndicator":"Yes","beginDate":"2010-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3261485","version":"1","preferredName":"Minimum Nuclei Positive Percent Number","preferredDefinition":"The smallest possible quantity._Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)_An observation confirming something, such as the presence of a disease, condition, or microorganism._Percentage; a fraction or ratio with 100 understood as the denominator._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"3261485v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":null,"minValue":"0","maxValue":"100","decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3261484","version":"1","preferredName":"Minimum Nucleus Positive Finding Percentage Number","preferredDefinition":"The smallest possible quantity.:Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed):An observation confirming something, such as the presence of a disease, condition, or microorganism.:Percentage; a fraction or ratio with 100 understood as the denominator.:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"3261484v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimum","conceptCode":"C25570","definition":"The smallest possible quantity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Nucleus","conceptCode":"C13197","definition":"A body within the cell, surrounded by a membrane, within which lie the chromosomes, one or more nucleoli, combined with proteins, and exhibits mitosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2D3571-0267-A9F2-E040-BB89AD431895","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-10","modifiedBy":"ONEDATA","dateModified":"2011-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2D3571-0278-A9F2-E040-BB89AD431895","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-10","modifiedBy":"COOPERM","dateModified":"2011-08-16","changeDescription":"Released per approval by T.Lichtenberg. mc 8/16/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If HER2/ErbB2 percentage scor","type":"Preferred Question Text","description":"If HER2/ErbB2 percentage score was used to determine the positivity for this patient what was the cut off for positivity?","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA3BED77-DE6C-8A24-E040-BB89AD430FA9","latestVersionIndicator":"Yes","beginDate":"2011-08-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-11","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Released per TCGA approval by T.Lichtenberg. mc 8/16/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}